Biosimilar medicines: considering brand equivalence /substitution Page last updated: 29 June 2018 Public Summary Document (PSD) March 2018 PBAC Meeting - (PDF 135 KB) Public Summary Document (PSD) March 2018 PBAC Meeting - (Word 42 KB)